Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

MRI of occult breast carcinoma in a high-risk population.

Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD.

AJR Am J Roentgenol. 2003 Sep;181(3):619-26.

PMID:
12933450
2.

MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer.

Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF, Menell JH, Van Zee KJ, Dershaw DD.

AJR Am J Roentgenol. 2003 Feb;180(2):333-41.

PMID:
12540428
3.

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.

Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK.

Cancer. 2004 Feb 1;100(3):479-89.

4.

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O'Loughlin M, Harms S, Bluemke DA; International Breast MRI Consortium Working Group.

Cancer. 2005 May 1;103(9):1898-905.

5.

Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.

Port ER, Park A, Borgen PI, Morris E, Montgomery LL.

Ann Surg Oncol. 2007 Mar;14(3):1051-7. Epub 2007 Jan 7.

PMID:
17206485
6.

Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.

Strigel RM, Eby PR, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2010 Sep;195(3):792-8. doi: 10.2214/AJR.09.4081.

PMID:
20729462
7.

Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.

Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ; Radiologist Investigators of the Radiologic Diagnostic Oncology Group V.

Acad Radiol. 2004 Mar;11(3):293-308.

PMID:
15035520
8.

MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.

Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK.

AJR Am J Roentgenol. 2003 Apr;180(4):901-10.

PMID:
12646427
9.

Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.

Liberman L, Sama M, Susnik B, Rosen PP, LaTrenta LR, Morris EA, Abramson AF, Dershaw DD.

AJR Am J Roentgenol. 1999 Aug;173(2):291-9.

PMID:
10430122
10.

Preoperative MR imaging-guided needle localization of breast lesions.

Morris EA, Liberman L, Dershaw DD, Kaplan JB, LaTrenta LR, Abramson AF, Ballon DJ.

AJR Am J Roentgenol. 2002 May;178(5):1211-20.

PMID:
11959734
11.

Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy.

Liberman L, Holland AE, Marjan D, Murray MP, Bartella L, Morris EA, Dershaw DD, Wynn RT.

AJR Am J Roentgenol. 2007 Mar;188(3):684-90.

PMID:
17312054
12.

A cluster of microcalcifications: women with high risk for breast cancer versus other women.

Uematsu T, Kasami M, Yuen S.

Breast Cancer. 2009;16(4):307-14. doi: 10.1007/s12282-009-0100-5. Epub 2009 Apr 7.

PMID:
19350360
13.

Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.

Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW.

Breast Cancer Res. 2012 Jan 9;14(1):R10.

14.

Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ.

Bae MS, Moon WK, Cho N, Chang JM, Seo M, Park IA, Han W.

AJR Am J Roentgenol. 2013 Sep;201(3):684-91. doi: 10.2214/AJR.12.10167.

PMID:
23971464
15.

Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size.

Liberman L, Mason G, Morris EA, Dershaw DD.

AJR Am J Roentgenol. 2006 Feb;186(2):426-30.

PMID:
16423948
16.

Ductal enhancement on MR imaging of the breast.

Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK.

AJR Am J Roentgenol. 2003 Aug;181(2):519-25.

PMID:
12876038
17.

Underestimation of breast cancer with II-gauge vacuum suction biopsy.

Philpotts LE, Lee CH, Horvath LJ, Lange RC, Carter D, Tocino I.

AJR Am J Roentgenol. 2000 Oct;175(4):1047-50.

PMID:
11000162
18.

Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.

Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DS, Geller BM, Key CR, Maygarden SJ, Ballard-Barbash R.

Cancer. 2006 Feb 15;106(4):732-42.

19.

Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.

Tolmos J, Cutrone JA, Wang B, Vargas HI, Stuntz M, Mishkin FS, Diggles LE, Venegas RJ, Klein SR, Khalkhali I.

J Natl Cancer Inst. 1998 Jun 3;90(11):846-9.

20.

Screening breast MR imaging in women with a history of lobular carcinoma in situ.

Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA.

Radiology. 2011 Nov;261(2):414-20. doi: 10.1148/radiol.11110091. Epub 2011 Sep 7.

PMID:
21900617
Items per page

Supplemental Content

Write to the Help Desk